Axsome Therapeutics, Inc. (AXSM)
NASDAQ·Healthcare·Biotechnology
$257.12
+1.32%
Mkt Cap $12.10B
Analyst Ratings
Buy
26
Hold
2
Sell
0
Price Target (55 analysts)
$223.00
Range $200.00 – $260.00
Implied Upside
-13.3%
Consensus $223.00 vs current $257.12